• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢呋辛用于软组织感染和败血症。

Cefuroxime in soft tissue infections and septicaemia.

作者信息

Hugo H, Dornbusch K, Sterner G

出版信息

Scand J Infect Dis. 1980;12(3):227-30. doi: 10.3109/inf.1980.12.issue-3.11.

DOI:10.3109/inf.1980.12.issue-3.11
PMID:7433923
Abstract

Data are presented on the absorption, antibacterial activity, clinical efficacy and side effects of cefuroxime in 33 cases with proven bacterial infection in soft tissues and in patients with septicaemia. The drug was administered mainly intramuscularly (i.m.) but also intravenously (i.v.). Peak serum concentrations 1 h after an injection of 750 mg cefuroxime i.m. were between 16-25 mug/ml. After 8 h the levels were mostly < 4 mug/ml in patients with normal renal function. I.v. injection gave only slightly higher maximum serum level obtained was approximately 40 mug/ml. No accumulation of the drug occurred in patients with normal renal function. Cefuroxime was active against all the gram-positive bacteria isolated from our patients as well as most of the gram-negatives. The clinical effect was satisfactory in 96%. The drug was well tolerated. Side effects were slight and relatively few.

摘要

本文给出了头孢呋辛在33例确诊为软组织细菌感染患者和败血症患者中的吸收、抗菌活性、临床疗效及副作用的数据。药物主要通过肌肉注射给药,但也有静脉注射给药。肌肉注射750mg头孢呋辛1小时后血清峰值浓度在16 - 25μg/ml之间。肾功能正常的患者8小时后血药浓度大多<4μg/ml。静脉注射的最高血清水平仅略高,约为40μg/ml。肾功能正常的患者未出现药物蓄积。头孢呋辛对从我们患者中分离出的所有革兰氏阳性菌以及大多数革兰氏阴性菌均有活性。临床有效率为96%。该药物耐受性良好。副作用轻微且相对较少。

相似文献

1
Cefuroxime in soft tissue infections and septicaemia.头孢呋辛用于软组织感染和败血症。
Scand J Infect Dis. 1980;12(3):227-30. doi: 10.3109/inf.1980.12.issue-3.11.
2
[Prevention and treatment of postoperative pyoinflammatory complications and cefuroxime].术后脓性炎症并发症的防治与头孢呋辛
Antibiot Khimioter. 1999;44(6):27-32.
3
Cefuroxime in the treatment of neonates.头孢呋辛用于新生儿治疗。
Arch Dis Child. 1982 Jan;57(1):59-62.
4
Studies with cefuroxime: a new beta-lactamase resistant cephalosporin.头孢呋辛的研究:一种新型耐β-内酰胺酶头孢菌素。
Chemotherapy. 1979;25(4):214-21. doi: 10.1159/000237842.
5
Clinical study of cefuroxime in the treatment of lower respiratory tract infections.
Curr Med Res Opin. 1980;6(7):466-71. doi: 10.1185/03007998009109469.
6
[Review [new antibiotics series I]: cefuroxime (author's transl)].[综述(新抗生素系列I):头孢呋辛(作者译)]
Jpn J Antibiot. 1982 Feb;35(2):283-95.
7
[Laboratory and clinical studies on cefuroxime (author's transl)].头孢呋辛的实验室及临床研究(作者译)
Jpn J Antibiot. 1979 Dec;32(12):1211-8.
8
The intraocular penetration of cefuroxime after parenteral administration.头孢呋辛经胃肠外给药后的眼内渗透性。
Br J Ophthalmol. 1979 Oct;63(10):687-9. doi: 10.1136/bjo.63.10.687.
9
[Study of cefuroxime in pediatric field (author's transl)].
Jpn J Antibiot. 1979 Nov;32(11):1165-77.
10
Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice.FCE 22891与头孢呋辛酯及头孢克肟在小鼠肺部和皮下感染中的活性比较
J Antimicrob Chemother. 1989 Mar;23 Suppl C:149-55. doi: 10.1093/jac/23.suppl_c.149.